Global Injectable Drug Delivery Market Trends and Forecast to 2024


Dublin, July 21, 2017 (GLOBE NEWSWIRE) -- The "Global Injectable Drug Delivery Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.

The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of this market are the increasing use of biologics, rising prevalence of chronic diseases, increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain). These factors increase the demand for devices such as safety syringes, prefilled syringes, and auto-disabled syringes. On the other hand, safety concerns regarding the use of injectables, increased risk of blood-borne infections due to injectables, and presence of other drug delivery methods (such as oral and transdermal) may hinder the growth of the market.

The global injectable drug delivery market have been segmented On the basis of product type into devices and formulations. Devices are further segmented into conventional injection devices and self-injection devices. Formulations are further segmented into conventional drug delivery, novel drug delivery, and long-acting injection formulations.

Scope of the Report

  • Based on applications the market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
  • On the basis of usage pattern the global injectable drug delivery market is segmented into curative care, immunization and, others.
  • Based on end-user the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.

Key Topics Covered:

1 Introduction
1.1. Overview of the Global Injectable Drug Delivery Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3. Stakeholders

2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at the Global Injectable Drug Delivery Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Key Data Points from Secondary Sources
2.2.6. Porter's Five Forces Matrix
2.4. Global Injectable Drug Delivery Market: Research Snapshot
2.5. Assumptions

3 Market Landscape Summary

4 Premium Insights
4.1. Overview
4.2. Global Injectable Drug Delivery Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Rising Prevalence of Chronic Diseases
4.3.1.2. Incresing Demand of Self Injection Devices
4.3.1.3. Growth of Bilogics and Biosimilars Market
4.3.1.4. Technological Advancements in Drug Delivery Market
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies

5 Injectable Drug Delivery Market, by Type
5.1. Overview
5.2. Global Injectable Drug Delivery Market, by Type
5.2.1. Injectable Drug Delivery Devices
5.2.2. Injectable Drug Delivery Formulations

6 Injectable Drug Delivery Devices Market, by Product Type
6.1. Overview
6.2. Conventional Injection Devices
6.2.1. by Material
6.2.1.1. Glass
6.2.1.2. Plastic
6.2.2. by Product
6.2.2.1. Empty Syringes
6.2.2.2. Prefilled Syringes
6.2.3. by Usability
6.2.3.1. Reusable Syringes
6.2.3.2. Disposable Syringes
6.3. Self Injection Devices
6.3.1. Needle Free Injectors
6.3.1.1. by Product
6.3.1.1.1. Empty Needle Free Injectors
6.3.1.2. 2. Prefilled Needle Free Injectors
6.3.1.2. by Technology
6.3.1.2.1. Jet Based Needle Free Injectors
6.3.1.2.2. Spring Based Needle Free Injectors
6.3.1.2.3. Laser Powered Needle Free Injectors
6.3.1.2.4. Vibration Based Needle Free Injectors
6.3.1.3. by Usability
6.3.1.3.1. Reusable Needle Free Injectors
6.3.1.3.2. Disposable Needle Free Injectors
6.3.2. Auto Injectors
6.3.2.1. by Product
6.3.2.1.1. Empty Auto Injectors
6.3.2.2. 2. Prefilled Auto Injectors
6.3.2.2. by Technology
6.3.2.2.1. Automated Auto Injectors
6.3.2.2.2. Manual Auto Injectors
6.3.2.3. by Design
6.3.2.3.1. Standardized Auto Injectors
6.3.2.3.2. Customized Auto Injectors
6.3.2.4. by Usability
6.3.2.4.1. Reusable Auto Injectors
6.3.2.4.2. Disposable Auto Injectors
6.3.3. Pen Injectors
6.3.3.1. by Product
6.3.3.1.1. Single Chambered Pen Injectors
6.3.3.2. 2. Dual Chambered Pen Injectors
6.3.3.2. by Design
6.3.3.2.1. Standardized Pen Injectors
6.3.3.2.2. Customized Pen Injectors
6.3.3.3. by Usability
6.3.3.3.1. Reusable Pen Injectors
6.3.3.3.2. Disposable Pen Injectors
6.3.4. Wearable Injectors
6.3.5. Other Injectable Devices

7. Injectable Drug Delivery Formulation Market, by Product Type
7.1. Overview
7.2. Conventional Drug Delivery Formulations
7.2.1. Solutions
7.2.3. Reconstitued/Lyophilized Formulations
7.2.3. Suspensions
7.2.3. Emulsions
7.3. Novel Drug Delivery Formulations
7.2.1. Colloidal Dispersions
7.2.1.1. Liposomes
7.2.1.2. Niosomes
7.2.1.3. Polymeric Mixed
7.2.1.4. Nanoparticles
7.2.1.4.1. Nanosuspensions
7.2.1.4.2. Nanoemulsions/Microemulsions
7.2.1.4.3. Solid Lipid Nanoparticles
7.2.2. Microparticles
7.2.2.1. Microspheres
7.2.2.2. Microcapsules
7.2.3. Long Lasting Formulations

8. Injectable Drug Delivery Market, by Application
8.1. Overview
8.2. Autoimmune Diseases
8.2.1. Rheumatoid Arthritis
8.2.2. Multiple Sclerosis
8.2.3. Chron's Disease
8.2.4. Psoriasis
8.2.5. Other Autoimmune Dideases
8.3. Hormonal Disorders
8.3.1. Diabetes
8.3.2. Anemia
8.3.3. Reproductive Health Diseases
8.3.4. Antithrombotic/Thrombolytic Therapy
8.3.5. Growth Hormone Deficiency (GHD)
8.4 Orphan Diseases
8.5 Oncology
8.6 Others
8.6.1. Pain Management
8.6.2. Allergy Treatment
8.6.3. Aesthetic Treatment
8.6.4. Hepatitis C
8.6.5. Hemophilia

9. Injectable Drug Delivery Market, by Usage Pattern
9.1. Overview
9.2. Curative Care
9.3. Immunizations
9.4. Other Usage Patterns (Blood Transfusion, Blood Products, and Contraceptives)

10 Injectable Drug Delivery Market, by Mode of Administration
10.1. Overview
10.2. Skin
10.3. Circulatory/Muskoskeletal
10.4. Organs
10.4. Central Nervous System

11 Injectable Drug Delivery Market, by End Users
11.1. Overview
11.2. Hospitals and Clinics
11.3. Home Healthcare Settings
11.4. Research Laboratories
11.5. Pharmaceutical and Biotechnological Companies
11.6. Others

12 Injectable Drug Delivery Market, by Distribution Channel
12.1. Overview
12.2. Direct Tenders
12.3. Hospital Pharmacy
12.4. Pharmacy Stores
12.5. Online Pharmacy
12.6. Others

13 Injectable Drug Delivery Market, by Geography

14 Injectable Drug Delivery Market: Competitive Landscape

15 Injectable Drug Delivery Market, Company Profiles

- Alkermes Plc
- Baxter International, Inc.
- Becton, Dickinson and Company
- Eli Lilly and Company
- Gerresheimer AG
- Pfizer, Inc.
- Sandoz
- Schott AG
- Terumo Corporation
- Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/research/96b4t7/global_injectable



            

Contact Data